Trial intelligence / Profile preview

Magnesium sulfate versus tramadol added to ropivacaine for analgesia onset in lower limb orthopedic surgery

IRCT20130812014333N116Phase 3Completed

Sponsor
Kermanshah University of Medical Sciences
Start
Mar 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, double-blind trial of ropivacaine, magnesium sulfate and tramadol in postoperative pain (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoints: onset of analgesia, level of block and 3 more. Started Mar 2019; status: completed.

02

Drugs

ropivacainemagnesium sulfatetramadol
03

Conditions

postoperative pain

Beyond the preview

Go deeper on IRCT20130812014333N116.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20130812014333N116.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call